Expectant mothers can test to determine the risk of Down syndrome in their baby before the baby is even born. The current process involves a combination of ultrasound and blood test. Women who are ...
Sequenom, Inc. has announced new positive data from the prospective clinical studies using the Company’s noninvasive SEQureDx™ technology, enabling the detection of fetal aneuploidy from maternal ...
Prenatal screening for Down syndrome (DS) is offered to all pregnant people receiving antenatal care in Great Britain, with the goal of providing relevant impartial information to support their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results